Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Ltd has informed the exchanges that its Board of Directors will meet on Friday, 30 January 2026 at the registered office. The main agenda is to consider and approve the unaudited financial results (both standalone and consolidated) for the third quarter and nine months ended 31 December 2025, along with taking on record the limited review report of the statutory auditors. This is a standard SEBI-mandated advance intimation under Regulation 29 of the LODR Regulations, and no financial numbers or performance details are disclosed in this filing.
This is a routine procedural filing with no direct impact on the stock. Investors should watch for the actual Q3 results announcement on 30 January 2026 to assess the company's earnings performance for the quarter.